What is Painreform Ltd (PRFX) stock price today?

Painreform Ltd (PRFX) currently trades at $1.88 per share. The stock has a market capitalization of $1.72M and a P/E ratio of —x.

Is PRFX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Painreform Ltd has a Smart Value Score of 25/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is the PRFX stock price target for 2026?

WallStSmart's 12-month price target for Painreform Ltd is $0.90.

What is Painreform Ltd's revenue and earnings?

Painreform Ltd has trailing twelve-month (TTM) revenue of $17000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-7.47.

PRFX

Painreform Ltd

NASDAQ: PRFX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$1.88

-7.84% today

Updated 2026-04-29

Market cap

$1.72M

P/E ratio

—

P/S ratio

101.35x

EPS (TTM)

$-7.47

Dividend yield

—

52W range

$2 – $12

Volume

0.6M

Market cap

$1.72M

P/E ratio

—

P/S ratio

101.35x

EPS (TTM)

$-7.47

Dividend yield

—

52W range

$2 – $12

Volume

0.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.3

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$12.00

+538.30%

12-Month target

$0.90

-52.13%

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-3.96M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$86000.00	$0.00	$0.00	$17000.00	$17000.00
Net income	$-8.79M	$-9.34M	$-14.59M	$-4.84M	$-4.84M
EPS	—	—	—	—	$-7.47
Free cash flow	$-6.46M	$-6.69M	$-12.63M	$-3.96M	$-3.96M
Profit margin	-10,223.26%	—	—	-28,458.82%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PRFX	$1.72M	25	3.3	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Painreform Ltd trades at $1.88. Our Smart Value Score of 25/100 indicates the stock is weak. TTM revenue stands at $17000.00.

Frequently asked questions

What is Painreform Ltd's stock price?

Painreform Ltd (PRFX) trades at $1.88.

Is Painreform Ltd overvalued?

Smart Value Score 25/100 (Grade F, Strong Sell).

What is the price target of Painreform Ltd (PRFX)?

The analyst target price is $12.00, representing +538.3% upside from the current price of $1.88.

What is Painreform Ltd's revenue?

TTM revenue is $17000.00.

Company info

SectorHEALTHCARE

IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio101.35x

ROE-90.40%

Beta0.71

50D MA$2.60

200D MA$4.96

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.6M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

PRFX vs LLY →PRFX vs JNJ →PRFX vs ABBV →Stock screener →